Research Participants Wanted

New Opportunities

Systemic Allergic Reactions to SARS-CoV-2 Vaccination Study

Are you interested in getting vaccinated against COVID-19? 

We are looking for volunteers for a COVID-19 vaccine research study. 

The Systemic Allergic Reactions to SARS-CoV-2 Vaccination study is recruiting volunteers to receive one of the two mRNA vaccines - Pfizer BioNtech COVID-19 Vaccine or Moderna COVID-19 Vaccine. These are the same vaccines that have received emergency use authorization by the FDA and are being used at public vaccination sites. 

You may qualify if you are 18-69 years of age and:

  • You have a history of Severe Allergies, OR
  • You have been diagnosed with a Mast Cell Disorder, OR
  • You have a history of No Allergies

For more information, please contact the Sean N. Parker Center for Allergy and Asthma Research at 650-521-7237 or snpcenterallergy_inquiry@stanford.edu.


Healthy subjects needed for PET/MRI Study  

We are seeking participants 18-55 years old for our PET/MRI study with the recently developed in-human radiotracer C11-UBC-J for synapses in the brain. This is the first in-human tracer of the synapse in the brain. We are using this tracer to see if there is reduced synaptic density in schizophrenia compared to healthy individuals. 

  • One visit, if eligible, to Stanford Lucas Center for up to 4.5 hours of study participation 
  • 1.5 hour scan 
  • 1 hour of cognitive testing  
  • 1 hour clinical interview, if applicable  
  • $250 for completion of the study 

 

Potential risks/discomfort 

  • Injection of radioactive material required for PET scan  
  • Intravenous (IV) delivery of radiotracer needed  
  • Lying down for a long period of time  

 

For more information, contact us at (650)-849-0552 or email us at brain-research@stanford.edu 


Healthy Adults Needed for FLASH Study

Stanford University and the Palo Alto VA are seeking participants, ages 18-35, for a research study investigating the use of bright light to improve nighttime alertness and change the timing of the circadian clock.

  • Two separate lab stays, each consisting of:

            2-day/night stay at the VA Sleep Lab

            2 weeks of at-home sleep monitoring using a wrist-watch device

  • In lab performance will be tested using flight simulation software

 

Participants must be healthy, non-smokers, without sleep problems. Volunteers paid up to $700 for successful completion of both 2-day/night stays in VA Sleep Lab.

For more information, please contact Yvonne Quevedo at (650) 849-1971 or email yvonne.quevedo@va.gov

For further information regarding questions, concerns, or complaints about research, research related injury, and questions about the rights of research participants, please call (650) 723-5244 or call toll free 1-866-680-2906 or write the Administrative Panel on Human Subjects in Medical Research, Administrative Panels Office, Stanford University, Stanford, CA 94305-5401.


Recruitment for healthy controls for OCD Study

Interested in participating in research? The Stanford Translational OCD Research Program is looking for paid volunteers to participate in a research study at Stanford University. Participants are paid $200 for completion of the study. You will receive a picture of your brain after completing some games and participating in an fMRI scan.

  • $200 for completion in study
  • Help advance research for individuals suffering with OCD
  • Play games
  • Go home with a picture of your brain to show your friends and family

Contact: 650-723-4095, or ocdresearch@stanford.edu.


HERO-TOGETHER COVID-19 post-vaccination safety study

Health care workers are currently needed to participate in this large, virtual surveillance project with Pfizer and the Duke Clinical Research Institute to monitor health outcomes for those workers who have received a COVID-19 vaccine. HERO-TOGETHER leverages the HERO Registry, a nationwide community of more than 17,000 health care workers established early in the pandemic. This two-year study is open to all health care workers who have been vaccinated in the past 60 days. Approximately 20,000 participants will answer surveys digitally over the next two years about their health and any unexpected medical care received. Sign up to participate.


UNFEAR Study: Teletherapy for Social Anxiety 

Do you feel anxious about being judged by others? The Stanford STAR lab is recruiting for a study on Social Anxiety. 

If you meet the following criteria:

  • No major medical problems
  • No current therapy or medication for anxiety
  • Between 18 and 50 years of age
  • Have access to the internet through a smartphone or a computer with a camera
  • Live in the State of California

 

You may be eligible for a research study involving 

  • Questionnaires 
  • Free therapy
  • Compensation of $115 - $150

To see if you are eligible,take the online screening survey: https://redcap.link/UNFEAR.

Email unfearstudy@stanford.edu or call 650-498-1664.

Participant's rights questions, contact 1-866-680-2906.

We are working to integrate anti-racism into our research in part by making it more equitable, participatory, and representative. As part of this effort, we especially invite Black, Latino/a/x, and Indigenous people to consider enrolling in our study. If you would like to learn more or have questions about our lab’s Commitment to Anti-Racism and how we aim to support BIPOC participants, please visit our website or email us at unfearstudy@stanford.edu.


Confirming the Efficacy/Mechanism of Family Therapy for Children with Low Weight Avoidant/Restrictive Food Intake Disorder (ARFID) 

Children ages 6-12 with a diagnosis of Avoidant/Restrictive Food Intake Disorder (ARFID) and their families are invited to participate in a Family-Based Treatment (FBT) vs. a manualized Non-Specific Care (NSC) research study through the Stanford Department of Psychiatry and Behavioral Sciences. The study consists of 14 one-hour telehealth sessions in either treatment arm, along with required medical management, over the course of 4 months. Treatment will be provided by doctoral-level, highly skilled therapists.

Who Can Participate?

  • Children ages 6-12
  • Current diagnosis of ARFID
  • Able to speak English
  • Living with at least one parent (the whole family will be enrolled for treatment)
  • Medically stable for outpatient treatment
  • Able to make a 6-month commitment

 

For more information, or to sign up for the study, please email Eliza at arfidstudy@stanford.edu, or call her at (650) 723-5521. Please reach out to Eliza with any questions or concerns!


The Effects of Micro Fragmented Adipose Tissue (MFAT) Injections on Knee Osteoarthritis

We aim to determine whether MFAT injection as an alternative therapy in patients with degenerative arthritis will result in improved clinical outcomes and structural improvement compared to conventional therapy. This study will be a randomized controlled trial to compare outcomes between intra-articular injection of MFAT and intra-articular injection of corticosteroid. We are recruiting patients who are 25-75 years old, diagnosed with mild to moderate osteoarthritis of the knee(s), and have previous trial and failure of conservative therapy.

For more information, please email jessn16@stanford.edu or call (650)723-0003.  


MKET Study

We are actively screening individuals for our MKET (Mechanisms of KETamine) Study. Do you have OCD? Are you 18-65 years old? Not taking medications or willing to work with your primary doctor for a trial off your OCD medications?

You may be eligible for a study with these possible benefits:

  • Free diagnostic evaluation
  • Free scan of your brain and picture
  • Free test of your memory and attention
  • Compensation of $400 after study completion

 

Contact: 650-497-0802 or ocdresearch@stanford.edu for more information. https://med.stanford.edu/rodriguezlab/research/ocd-research/mket-study.html

Physician Investigator: Carolyn Rodriguez, M.D, Ph.D., Stanford Medical Center

https://med.stanford.edu/profiles/carolyn-rodriguez?tab=bio

Funding: National Institutes of Mental Health (NIMH)

Stanford IRB# 34622

For Participant's rights questions please contact 1-866-680-2906.


Longitudinal Effects of Dietary Fiber Supplementation

The study uses a big data systems biology approach to find detailed effects of purified dietary fiber supplementation. Genomic and microbiome data will be returned participants. Volunteers must be 18 years of age or older, and not pregnant. During the initial visit, researchers will collect samples for genomic analysis. The participation period will have four cycles that take approximately seven weeks from start to finish. For more information contact Alessandra Celli.


Molecular Profiling of COVID-19 Vaccine Response – At-home Microsampling Study

You are invited to participate in a research study to better understand your how body responds to COVID-19 vaccination. Participants must be 18 years or older, live in the United States, and not yet received any COVID-19 vaccine.  

We hope to learn more about COVID-19 vaccination through monitoring of molecules in your blood and stool using multi-omics profiling. “Multi-omics” means we will be looking at many different types of molecules, including: metabolites, lipids, proteins, and antibodies.

You will receive a study kit and complete the study from home. Your first vaccine appointment should be at least 2 week after the date you enroll in the study. For details and to enroll, please visit https://snyderlabs.stanford.edu/vaccine. For questions, please email microsampling@stanford.edu.


Stanford’s new COVID-19 Study Directory: https://stan.md/covid19-participate

Browse and connect with actively recruiting COVID-19 studies at Stanford.

Stanford Medicine researchers and scientists have launched dozens of research projects as part of the global response to COVID-19. Some aim to prevent, diagnose and treat the disease; others aim to understand how it spreads and how people’s immune systems respond to it.

By participating in our COVID-19 clinical research, you help accelerate medical science by providing valuable insights into potential treatments and methods of prevention.

Stanford Researchers: To have your study listed here, following IRB and COVID-19 Review Panel approvals, please contact Stanford Research Participation at EngageParticipants@stanford.edu


Negative Symptoms of Schizophrenia

Stanford researchers are recruiting participants with schizophrenia or schizoaffective disorder who struggle with negative symptoms (such as inactivity, social withdrawal and emotional inexpressiveness). The purpose of this study is to find out what effects the study medication RO6889450 has on the negative symptoms of schizophrenia or schizoaffective disorder. If you would like further information or you’re interested in taking part please contact us at inspire-research@stanford.edu.


The Gratitude Study

Stanford researchers are recruiting participants with schizophrenia who have experienced weight gain due to taking antipsychotic medications. The purpose of this study is to find out whether an investigational study drug, Miricorilant, is safe and effective in reducing weight gain in participants taking antipsychotic medications. If you would like further information or you’re interested in taking part please contact us at inspire-research@stanford.edu.


Improving Cognition via Exercise in Schizophrenia (ICE)

Participants are invited to take part in a research study investigating the influence of exercise on cognitive functioning in individuals with schizophrenia. This study will examine the impact of exercise training on cognition, suicide risk, daily functioning, and biomarkers of cognitive change and suicidality in people with schizophrenia. Eligible participants will be randomized into aerobic exercise training or stretching and toning exercise training. Participants in both groups will take part in a 12-week, 3 times per week, 1-hour training program, in addition to their regular treatment. If you’re interested in taking part please contact us at inspire-research@stanford.edu.


Human Connectome study 

The research study is aimed at understanding behaviors and brain circuits that relate to anxiety and depression. The study will investigate the underlying brain circuits associated with these disorders, the relationship between the circuits and specific symptoms and behaviors, and how to use the brain circuit properties to predict symptom change. Participants must be 18-35 years of age and be currently experiencing depression and/or anxiety symptoms. Learn more and register for the study.


Early Detection of COVID-19 Infection Symptoms Using Wearable Devices - Empatica devices

Through this study, we are aiming to understand if the use of wearable devices, such as fitness trackers like the Empatica watch, can be used to early detect symptoms of infection disease, including the new COVID-19 respiratory infection. For this study, we will specifically target people at high risk of COVID-19 exposure. In light of the large invisible caseload and high transmission rates of COVID-19, as well as the lack of sufficient, widely available testing kits, alternative methods for early disease detection could provide a significant public health benefit during the outbreak. Our previous work has indicated that heart rate data measured using smartwatches can be useful for early detection of infectious disease. We have developed an algorithm, Change-of-Heart, that identified extremely outlying heart rate measurements and we showed that these outliers were often associated with infection. Participants will enroll for this 30-day-study, during which they must wear the Empatica watch and collect daily saliva samples using the provided at-home COVID-19 testing kits.

Please email covid19_empatica@stanford.edu to enroll.


Stanford Home Sleep Study

The Stanford Home Sleep Study is seeking participants with or without sleep-time teeth grinding for a remote study that investigates the relationship between sleep and well-being. Receive a personalized sleep report, earn up to $80, and provide information that may help us develop interventions aimed at improving sleep and quality of life.

Learn more here. 

For questions, email homesleep@stanford.edu.


 Stanford Autism Spectrum Disorder and Intellectual Disability Research Registry

Does your child have autism? Researchers at Stanford University are developing a Research Registry to better understand the causes and treatment of Autism Spectrum Disorder (ASD) and Intellectual Disability (ID). The Research Registry will allow researchers to identify and recruit patients who might be eligible for participation in future research studies, and review and study the medical records of your child to help answer questions about ASD and/or ID and its treatment. In order to be part of the Research Registry, your child must have a diagnosis of Autism Spectrum Disorder and/or Intellectual Disability.  There is no cost to participate. For more information, call (650) 736-1235. Register here: http://med.stanford.edu/autism/registry.html


Stanford Hoarding Disorder Research Study

If you have difficulty with clutter, are feeling overwhelmed and needing help, and over 55, you may be eligible to receive peer-support group sessions paired with virtual reality (VR) sessions at no cost to you.

Physician Investigator: Carolyn Rodriguez, M.D, Ph.D., Stanford Medical Center

For more information contact: clutterhelp@stanford.edu ; 650-497-2577

Learn more here. Participant's right questions, contact 1-866-680-2906.


Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic

The COVID-19 Pandemic and mitigation efforts have drastically disrupted daily life and increased stress, causing worse sleep quality for many individuals across the world. The CoPsyN Sleep lab at Stanford University is conducting a study of a brief, non-drug therapy for acute sleep problems that have started or worsened during the COVID-19 Pandemic. Volunteers who are 18 years or older, experiencing sleep difficulties since the COVID-19 Pandemic, and currently living in the United States will receive extensive sleep evaluation and individualized telehealth treatment. There is no in-person contact in this study. If interested, please fill out an interest form (https://redcap.stanford.edu/surveys/?s=XRPF4NTRFA&fbclid=IwAR3jaC3z0OhlwC86_Hf9le8R7BgYbfImpeJzVCfJfI8XRmij_cCjeZeYnFc) or email Allie at amorehse@stanford.edu


Stanford PanLab Human Connectome Study

Participants are needed for this study. Feeling a lack of motivation? Noticing changes in your appetite and sleep? Experiencing low mood? Interested in learning more about how this relates to the circuitry of your brain? You must be 18-35 years old. Learn more about the study. If you have questions call 1-866-680-2906.


Janssen COVID-19 ENSEMBLE Vaccine study

The Janssen COVID-19 ENSEMBLE Vaccine study at Stanford (PI: Dr. Grant, ID) will be open for participant visits starting Monday, Oct. 12. This is a Phase 3, Randomized, Double-Blinded, Placebo Controlled trial. This study is available to essential workers as well as the public. Learn more about the study here.

Email the Stanford study team with any questions at vaccines_program@stanford.edu.


Treatment resistant depression study recruitment

Stanford researchers are recruiting participants with treatment resistant depression for a study to explore whether intravenous ketamine followed by the opioid buprenorphine produces more rapid and sustained anti-suicidal effects than ketamine followed by placebo. Researchers are recruiting 60 participants. Each participant will get one infusion of ketamine followed by four weeks of a medication or placebo. For information contact Jessica Hawkins at: jhawk@stanford.edu or call 650 723-8323.


COVID-19 long-term symptoms study

Stanford University researchers need your help to understand how COVID-19 symptoms evolve over time. Participants will be asked to fill out a brief online survey regarding their general health as well as symptoms that may have appeared after the COVID-19 illness began. The survey will repeat every three months for one year to assess change over time. Help spread the word and ask any adults you know who had or suspected they had COVID-19 to take this quick survey.


SPARK for Autism

SPARK for Autism seeks to speed up research and improve understanding of autism.  This includes learning what causes autism and how best to treat it. Stanford University and over 20 of the nation’s leading medical schools and autism research centers are part of this effort. Participating in SPARK is free and can be done entirely from home. Registration can be done entirely online at www.SPARKforAutism.org/stanford  and typically takes about 20 minutes. To participate in SPARK, please register, complete a few questionnaires online, and provide a saliva sample using a saliva collection kit that will be shipped directly to your home. Please contact sparkstudy@stanford.edu with any questions.


Study on treatment resistant depression with suicidal ideation

A new study funded by the American Foundation for Suicide Prevention is recruiting people currently experiencing symptoms of depression and suicidal thoughts.  All eligible participants will receive one infusion of ketamine followed by four weeks of a medication or placebo. You may be eligible to participate in this six-week study if you are between 18-70 years of age and have not responded to previous depression treatment. Learn more about the study and complete an online screening form. Reach out to Jessica Hawkins with questions.


COVID-19 IRIS Study

The IRIS Study is currently seeking participants who have had symptoms of COVID-19 to learn more about infection recovery. Eligible subjects will be required to do an initial blood draw and participate in surveys, neuropsychological testing and a physical exam. There are two follow-up visits involving a chest x-ray and pulmonary function test. Participants will be compensated $80 per visit. For more information call (650) 498-7284 or email Mallika Rao.


Favipiravir study for asymptomatic and mild COVID-19

Favipiravir, an antiviral medicine, is currently used to treat influenza in some countries as well as mild and asymptomatic COVID-19. Researchers at Stanford Medicine are investigating if favipiravir may help patients get better faster, prevent them from getting worse and lower the chance of infection. The study is open to people within two days after they have tested positive for COVID-19. Learn more about the study. If you are interested in participating in the study, email treatcovid@stanford.edu.